The University of Kansas Cancer Center

https://www.kucancercenter.org/

 

KU Hematology & Medical Oncology Review 2019
R

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal Cell Carcinoma

By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
By KU Hematology & Medical Oncology Review 2019 FEATURING Rahul Parikh
0 views
August 22, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

08:44
Johnson & Johnson

Management and Proactive Care of Adverse Events Associated with Loca…

Feat. J. Sabari, A. Spira
Genitourinary
11:59
KU Hematology & Medical Oncology Review 2019

KU ASCO GU 2019 Updates: Enzalutamide vs. Apalutamide in Metastatic …

Feat. R. Parikh
11:41
KU Hematology & Medical Oncology Review 2019

KU ASCO 2019 Updates: VEGF-TKI and/or PD-1/PD-L1 in Metastatic Renal…

Feat. R. Parikh